Skip to main content
Novartis
language-selector-globe
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
United States | English
    • About 
      • Novartis in the UK 
      • Partnerships 
        • Collaborative working 
        • External funding 
        • Patient group partnership 
      • Sponsorships 
      • Diseases 
      • Strategy 
      • People and culture 
      • Who we are 
      01077_144dpi_16by9_PPT_RGB
      About
    • Patients and caregivers 
      • External funding 
      • Patient group partnership 
      Doctor and Patient
      Patients and Caregivers
    • Healthcare professionals 
      • For UK healthcare professionals 
      Healthcare Professional Writing
      Healthcare Professionals
    • ESG 
      • Ethical behaviour 
        • Code of Ethics 
        • Speakup 
      • Ethics, risk and compliance 
      • Access 
      • Environmental sustainability 
      • Global health 
      • Transparency 
        • Healthcare professional payment transparency 
      Young girl in doctor's office
      ESG
    • News 
      • Stories 
      • News archive 
      • Novartis UK press office 
      colleagues in discussion
      News
    • Careers 
      • Career search 
      • Personal growth 
      • Early talent 
      • How we work 
      • Well-being 
      • Career programmes 
      • Awards and recognition 
      Business person with a whiteboard behind them in a modern office
      Careers
    • Contact 
    Home
    Home
Global Search Navigation
  • All
  • Site Pages
  • Media Releases
  • Stories
Sort by
Hide Filters
Showing 236 results
  • St George’s University Hospitals NHS Foundation Trust

  • Enderby Medical Centre, Shortridge Lane, Enderby, LE19 4LY for and on behalf of the North Blaby Primary Care Network

  • Media Release / Apr 24, 2025

    Kisqali (ribociclib) now available for some people diagnosed with early breast cancer through the Cancer Drugs Fund (CDF) in England

    Today, the National Institute for Health and Care Excellence (NICE) published its preliminary optimised recommendation1 for ribociclib to be used as adjuvant treatment in combination with an…
  • Little Horton Lane, for and on behalf of the Horton Primary Care Network

  • South Doc Services (SDS) MyHealthcare Limited

  • NHS Grampian

  • Croft Medical Centre, 2 Glen Road, Oadby, Leicester, LE2 4PE, for and on behalf of the Cross Counties Primary Care Network

  • Cross counties PCN The Croft Medical Centre (the “CW Partner”),2 Glen Road, Leicester, LE2 4PE Together, (the “Parties”)

  • Enderby Medical Centre, Shortridge Lane, Enderby, LE19 4LY (“Lead Practice”) for and on behalf of the North Blaby Primary Care Network (the “North Blaby PCN”), together referred to throughout as the “Collaborator” or the “CW Partner”

  • The Village Green Surgery, for and on behalf of the Wallsend Primary Care Network

Pagination

  • ‹ Previous page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 24
  • › Next page

Related News & Media

Bold partner video screenshot
Novartis UK launches new bold partner for progress film

Novartis UK

Navigate Novartis
  • Patients and caregivers
  • ESG
  • News
  • Careers
Media Center
  • News archive
  • Stories
Our Portfolio
  • Novartis clinical pipeline
  • Novartis product information
Other Novartis Websites
  • Healthcare Professional portal
  • Novartis global
  • Advanced accelerator applications
  • Novartis biome
  • Novartis clinical trials
Footer Bottom
© 2025 Novartis Pharmaceuticals UK Ltd
  • Privacy policy
  • Terms of use
  • Contact
  • Web accessibility
  • Modern slavery statement
  • Cookie settings
Novartis Site Directory
This site is intended for an audience in the UK